- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Nexalin Interview to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 142 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and LOBO EV Technologies Ltd. (Nasdaq:LOBO) on the RedChip Small Stocks, Big... ► Artikel lesen | |
| Fr | LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 111 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (Nasdaq:LOBO) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money... ► Artikel lesen | |
| 18.07. | Nexalin Technology, Inc.: Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery | 1 | GlobeNewswire (USA) | ||
| 01.07. | Nexalin Technology, Inc.: Nexalin Technology Announces Closing of $5.2 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| 28.06. | Pre-market Movers: Cosmos Health, Carisma Therapeutics, Elicio Therapeutics, Nexalin Technology, Accolade | 418 | AFX News | WASHINGTON COUNTY (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.45 A.M. ET).In the Green Cosmos Health Inc. (COSM) is up over 66%... ► Artikel lesen | |
| 28.06. | Why Is Nexalin Technology (NXL) Stock Down 35% Today? | 3 | InvestorPlace | ||
| 28.06. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.06. | Nexalin Technology stock slides on pricing stock offering to raise $5.2 million | 1 | Seeking Alpha | ||
| 28.06. | Nexalin Technology, Inc.: Nexalin Technology Announces Pricing of $5.2 Million Public Offering | 3 | GlobeNewswire (USA) | ||
| 26.06. | Nexalin Technology, Inc.: Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal | 109 | GlobeNewswire (Europe) | Study demonstrates strong statistical separation between patients receiving Nexalin's DIFS® technology in combination with escitalopram (Lexapro) vs sham group receiving escitalopram alone Two-thirds... ► Artikel lesen | |
| 24.06. | Nexalin Technology, Inc. - S-1/A, General form for registration of securities | 3 | SEC Filings | ||
| 21.06. | Why Are Nexalin Technology Shares Surging Friday? | 2 | Benzinga.com | ||
| 20.06. | Nano-Cap Nexalin Technology Secures US Patent For Stimulation Device For Alzheimer's And Dementia Treatment | 3 | Benzinga.com | ||
| 20.06. | Nexalin Technology, Inc.: Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia | 195 | GlobeNewswire (Europe) | HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") today announced that the United States Patent and Trademark Office (USPTO)... ► Artikel lesen | |
| 18.06. | Nexalin Technology, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.06. | Nexalin Technology, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 14.06. | Why Is Nexalin Technology (NXL) Stock Down 29% Today? | 2 | InvestorPlace | ||
| 13.06. | Nexalin Technology, Inc.: Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa) | 102 | GlobeNewswire (Europe) | HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation... ► Artikel lesen | |
| 04.06. | Nexalin Technology, Inc.: Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th | 1 | GlobeNewswire (USA) | ||
| 03.06. | Nexalin Technology, Inc.: FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity Headset Device | 116 | GlobeNewswire (Europe) | HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided feedback... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |
Das Unternehmen NEXALIN TECHNOLOGY INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,060 (+5,13 %) liegt der Kurs bei 1,230 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.
